State of Louisiana v. U.S. Food and Drug Administration

• FDA's 2023 REMS "lowered the standard of care" – Heartbeat weighs in on mifepristone coerced abortion case
• Heartbeat supports Louisiana’s “well-justified advocacy” for women in abortion pill case appeal
• Louisiana continues its battle against mail-order chemical abortion pills, citing state sovereignty, economic burden
• Women harmed by abortion drugs send a message to Todd Blanche